The present invention provides compounds of formula I which are inhibitors
of cathepsin S and as such are useful in the prevention and treatment of
cathepsin S dependent diseases and conditions including, but not limited
to, chronic obstructive pulmonary disease (COPD) and pain.
##STR00001##
